Karyopharm Therapeutics Inc. Available-for-sale Securities, Amortized Cost Basis
Karyopharm Therapeutics Inc. (KPTI) had Available-for-sale Securities, Amortized Cost Basis of $68.78 million as of 2021-09-30, per its 10-Q filed 2021-11-03.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2021-11-03
- 2021-09-30: Available-for-sale Securities, Amortized Cost Basis $68.78M.
- 2021-06-30: Available-for-sale Securities, Amortized Cost Basis $96.48M.
- 2021-03-31: Available-for-sale Securities, Amortized Cost Basis $143.42M.
- 2020-12-31: Available-for-sale Securities, Amortized Cost Basis $187.26M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2021-09-30 | $68.78M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $96.48M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $143.42M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $187.26M 10-Q · filed 2021-11-03 |
| 2020-09-30 | $219.48M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $241.52M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $181.58M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $135.12M 10-K · filed 2021-02-24 |
| 2019-09-30 | $101.51M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $141.52M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $180.88M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $212.39M 10-K · filed 2020-02-26 |
| 2018-09-30 | $110.12M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $131.19M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $104.09M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $107.12M 10-K · filed 2019-02-28 |
| 2017-09-30 | $104.56M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $125.47M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $124.66M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $125.48M 10-K · filed 2018-03-15 |
| 2016-09-30 | $132.47M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $127.73M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $144.24M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $151.34M 10-K · filed 2017-03-16 |
| 2015-09-30 | $186.12M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $231.43M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $233.47M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $63.80M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |